The most immediate symptom of cystic fibrosis in the lungs is that it makes breathing more difficult. The buildup of mucus blocks the airways and lines the walls of the lungs, making it more difficult to draw oxygen from each breath. A common analogy to the way cystic fibrosis restricts lung function is that it feels like breathing through a straw.
IV Solutions's blog
There are many cystic fibrosis treatments for clearing heavy mucus from the lungs, the most commonly known and prevalent symptom of CF. This is responsible for the primary cause of mortality (80%) in people with cystic fibrosis; respiratory failure.
Advances in treatment and technology have increased the prognosis from early childhood to 40 years and beyond. Each generation benefits from the most modern advancements in medicine and this number continues to rise.
Keeping your AlteraⓇ Nebulizer System clean and disinfected is important in ensuring that your treatment is as effective as possible. It only takes one unsanitary piece of your handset to introduce further infections or irritants into your respiratory system.
How do pets affect cystic fibrosis symptoms?
One of the more applicable studies on the effects of pets on people with cystic fibrosis were collected from 703 cystic fibrosis patients through the US CF Twin-Sibling Study. The study involved cystic fibrosis families who raised cats and/or dogs.
An important finding showed that the rate for respiratory infection for cystic fibrosis pet owners was no different than in households without pets. This suggests that, given the proper precautions, pets can be a part of life with cystic fibrosis.
There are generally two types of diabetes.
Type 1: When the pancreas stops making insulin
Type 2: When the body becomes unable to use insulin properlyCystic fibrosis-related diabetes has aspects of both these types of diabetes, but it is distinct in a number of ways.
Though cystic fibrosis affects many of the systems in the body, it is commonly recognized that the organs most profoundly affected by mucus build up are the lungs. The mucus build up, in itself, presents a challenge in breathing and consistently taking medication and breathing treatments to loosen and clear the mucus from the airways.
Coupled with the many opportunistic respiratory infections that commonly present themselves in cystic fibrosis cases, the long term damage to the lungs can become severe and offer few options for relief other than lung transplantation.
Tips for Preventing Lung Infections
There are now many methods of cystic fibrosis treatment for opportunistic infections in the lungs. Although most people with cystic fibrosis can expect to receive treatment for chronic bacterial infections, the best approach is always prevention.
Cystic fibrosis inheritance is passed on through a change in a gene on the 7th chromosome. This change results in the production of the protein CFTR(cystic fibrosis transmembrane regulator). This protein is the reason that the mucus is thick and builds up in people with cystic fibrosis.
Cystic fibrosis inheritance is passed on through autosomal recessive genes, meaning that it is necessary for a child to inherit the changed gene that produces the CFTR protein from BOTH parents in order to express the symptoms of CF.
Cystic fibrosis requires a complex treatment process that involves multiple medications. Many of the medications used to treat cystic fibrosis are specialty medicines with limited distribution. This means that only certain providers have permission to dispense these drugs and it can be difficult to find a provider that offers a comprehensive list of cystic fibrosis medications.
Cystic fibrosis is related to many symptoms throughout the body. The most profoundly affected systems have problems due to the build up of thick, sticky mucus.
The Respiratory Tract is the most notably affected organ since the buildup of mucus makes it difficult to breath and must constantly be treated and coughed out. The mucus is a great environment for opportunistic bacterial lungs infections, which is the principal reason for decline in lung function of people with cystic fibrosis.